BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11115733)

  • 1. Acute antipsychotic drug administration lowers body temperature in drug-free male schizophrenic patients.
    Shiloh R; Hermesh H; Weizer N; Dorfman-Etrog P; Weizman A; Munitz H
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):443-5. PubMed ID: 11115733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
    Mazure CM; Bowers MB
    J Affect Disord; 1998 Feb; 48(1):83-6. PubMed ID: 9495606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patients.
    Shiloh R; Bodinger L; Katz N; Sigler M; Stryjer R; Hermesh H; Munitz H; Weizman A
    Neuropsychobiology; 2003; 48(1):1-4. PubMed ID: 12886032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients.
    Dencker SJ; Giös I; Mårtensson E; Nordén T; Nyberg G; Persson R; Roman G; Stockman O; Svärd KO
    Psychopharmacology (Berl); 1994 Feb; 114(1):24-30. PubMed ID: 7846204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal temperature in schizophrenia patients.
    Shiloh R; Munitz H; Portuguese S; Gross-Isseroff R; Sigler M; Bodinger L; Katz N; Stryjer R; Hermesh H; Weizman A
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):537-47. PubMed ID: 15927092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for a new framework to understand the mechanism of all antipsychotics.
    Stip E; Liddle PF; Soucy JP
    J Clin Psychiatry; 2000 May; 61(5):387-8. PubMed ID: 10847316
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
    Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
    Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'.
    Altamura AC; Bareggi SR
    Int Clin Psychopharmacol; 2000 Sep; 15(5):303-4. PubMed ID: 10993133
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
    Weiss E; Kemmler G; Fleischhacker WW
    Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
    [No Abstract]   [Full Text] [Related]  

  • 11. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses.
    Gaertner I; Altendorf K; Batra A; Gaertner HJ
    J Clin Psychopharmacol; 2001 Apr; 21(2):215-22. PubMed ID: 11270919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.
    Coley KC; Carter CS; DaPos SV; Maxwell R; Wilson JW; Branch RA
    J Clin Psychiatry; 1999 Dec; 60(12):850-6. PubMed ID: 10665632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.
    Lahti AC; Weiler MA; Medoff DR; Tamminga CA; Holcomb HH
    Psychiatry Res; 2005 May; 139(1):19-30. PubMed ID: 15950442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients.
    Levine J; Caspi N; Laufer N
    Schizophr Res; 1997 Jul; 26(1):55-63. PubMed ID: 9376337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
    Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA
    Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
    Beresford T; Buchanan J; Thumm EB; Emrick C; Weitzenkamp D; Ronan PJ
    J Clin Psychopharmacol; 2017 Dec; 37(6):657-663. PubMed ID: 28984746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ;
    J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.